This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignee: Astrazeneca Ab. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Andrew Grier Buchanan: Innovator in Antibody Molecules
Introduction
Andrew Grier Buchanan is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Latest Patents
Andrew Grier Buchanan holds a patent for "Antibody molecules and conjugates." This patent relates to antibody molecules that bind to the epidermal growth factor receptor (EGFR) and/or c-Met, along with conjugates containing these antibody molecules. The applications of these antibody molecules and conjugates are particularly relevant in the treatment of cancer.
Career Highlights
Buchanan is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Frank Irvine Comer and Yariv Mazor. Their collective expertise enhances the innovative environment at AstraZeneca, fostering advancements in therapeutic solutions.
Conclusion
Andrew Grier Buchanan's work in antibody molecules exemplifies the intersection of innovation and healthcare. His contributions are vital in the ongoing fight against cancer, and his patent reflects a significant step forward in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile